Cargando…
Homocysteine Reduction for Stroke Prevention: Regarding the Recent AHA/ASA 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
Reduction of secondary ischemic stroke risk following an initial stroke is an important goal. The 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack assembles opportunities for up to 80% secondary stroke reduction. Homocysteine reduction was not included in the recommend...
Autores principales: | Brown, Craig, Wang, Jianhua, Jiang, Hong, Elias, Merrill F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559895/ https://www.ncbi.nlm.nih.gov/pubmed/37810545 http://dx.doi.org/10.2147/PGPM.S426421 |
Ejemplares similares
-
Relationship Among Homocysteine, Inflammation and Cognitive Impairment in Patients with Acute Ischemic Stroke and Transient Ischemic Attack
por: Cui, Lingyun, et al.
Publicado: (2021) -
The Role of Lipid-Lowering Treatment in the Secondary Prevention of Ischemic Stroke
por: Tsankof, Alexandra, et al.
Publicado: (2021) -
Transient ischemic attacks: predictability of future ischemic stroke or transient ischemic attack events
por: Gupta, Harsh V, et al.
Publicado: (2014) -
Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial
por: Amarenco, Pierre, et al.
Publicado: (2020) -
Dual Antiplatelet Therapy in Coronary Artery Disease: Comparison Between ACC/AHA 2016 and ESC 2017 Guidelines
por: Floyd, Christopher N
Publicado: (2020)